Navigation Links
Japan Vietnam Medical Instrument Company Ranked as One of Top 3 Companies in Vietnam
Date:7/18/2013

HO CHI MINH CITY, Vietnam, July 18, 2013 /PRNewswire/ -- Japan Vietnam Medical Instrument Company (JVC – www.ytevietnhat.com.vn) was ranked third overall on a list of Top 50 Performing Companies in Vietnam (Annual Top 50 Performing Companies in Vietnam Review).

The superior ranking - provided by a review panel and survey organized by Nhip Cau Dau Tu Magazine and Thien Viet Securities - was the result of high marks in both financial performance and qualitative measurements.

"We couldn't be more excited about this ranking – it is the first time we have had such wide recognition of our performance. Certainly, being seen as one of the best business is very meaningful to our team, our shareholders, and our clients," said Le Van Huong, Chairman and CEO of the Company.

David Zezza, a Director of AIM Capital Management and Managing Partner of Pacific Advantage Capital adds: "We are very pleased that the Company has achieved this result. The ranking is really further confirmation of the remarkable growth and performance of JVC through what has been a challenging environment."

On the financial side, JVC achieved some of the best results in the survey.  The Company was evaluated based on four factors: revenue growth, net profit growth, return on equity (ROE) and return on invested capital (ROIC). For the period from 2010 through 2012, the Company posted average revenue growth of 61%; net profit growth of 77%; ROE of 39%; and, ROIC of over 32%.

In terms of qualitative measures, the Company was also seen as a top performer based upon its strong business model and strategy, the quality of the management team, and the firm's ability to manage performance given the difficult global and regional environment.

Chairman Le Van Huong also adds that "We will continue to invest in growth and continue to press our strategy to become the leading one-stop shop of medical services, equipment, and consumables for hospitals, clinics and healthcare centers throughout the Vietnam.  Along the way, JVC will contribute to the modernization of the healthcare services industry in Vietnam."

The Annual Top 50 Performing Companies in Vietnam Review  are conducted by Nhip Cau Dau Tu - a local business and investment magazine in Vietnam – along with local securities company  Thien Viet Securities. The review and ranking evaluate strengths and weaknesses in business model, corporate governance, and vision of management in 2010 – 2012.

JVC, which is listed on the Ho Chi Minh Exchange (ticker symbol JVC), is the leading supplier of medical diagnostic equipment (X-rays, MRI's, Cat Scans, etc.) to health care facilities across Vietnam. 

For further questions please contact Hao Nguyen – hao@aim-capital.com or Ho Bich Ngocngochb@ytevietnhat.com.vn


'/>"/>
SOURCE Japan Vietnam Medical Instrument Company
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Empire Genomics Chooses Funakoshi as Japan Distributor
2. Regeneron and Bayer Announce Co-Promotion Agreement With Santen For EYLEA® (aflibercept) Injection in Japan
3. Accuray Rolls Out Comprehensive Customer Service Program in Japan
4. CPhI Japan Triumphs in the Prestigious AEO Excellence Awards
5. Japanese Market for Orthopedic Soft Tissue Repair & Sports Medicine
6. Pharmaceutical Supply Chain in Japan - Periodic Drug Price Revisions by National Health Insurance Increase Competition and Squeeze Profit Margins
7. Pfizer and Mylan Team Up to Establish Exclusive Long-Term Strategic Collaboration to Drive Sustained Growth of Generics Business in Japan
8. CMC Biologics Establishes Commercial Presence in Japan through Strategic Agreement with Innomedica
9. Japan Pharma Review: Outlook to 2017
10. The Japanese Cancer Association and Debiopharm Group Present Doctors Oshima and Tanaka with the 2012 JCA-Mauvernay Award for their Innovative and Outstanding Cancer Research
11. Sosei Group Corporation: QVA149 Filed by Licensing Partner as a Once-Daily Maintenance Treatment for COPD in Japan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... , March 29, 2017 Avelas Biosciences, Inc., a ... diagnosis through treatment, today announced that Carmine N. Stengone , ... company at the Needham & Company 16 th Annual Healthcare ... a.m. PDT) at the Westin Grand Central Hotel in ... ...
(Date:3/29/2017)... 2017 Research and Markets has announced the addition ... Centers & Forecast" report to their offering. ... Proton Therapy Market in Italy ... in 2016. There are currently three proton therapy centers in ... patients. In Italy , the first patients were treated ...
(Date:3/29/2017)... , Mar. 29, 2017 Research and Markets has ... Policy, Patients Treated at Proton Therapy Centers & Forecast" report to ... The South ... its current market size in 2016. The Untapped Proton Therapy Market for ... Billion USD in 2016. Proton Therapy plays an important ...
Breaking Medicine Technology:
(Date:3/29/2017)... ... March 29, 2017 , ... Wells Pharmacy ... attending prescribers at the upcoming World Congress, in Hollywood Florida April 6-8, 2017. ... recognized as the visionary leader in the training of physicians, scientists, and members ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... insight into the challenges employers face in trying to balance both short-term and ... benefits programs? Adding to the growing complexity, companies are finding that the ...
(Date:3/29/2017)... (PRWEB) , ... March 29, ... ... Manufacturer Alliance (GRMA) is growing as it continues developing an ANSI-approved, consensus-based ... industry. The organization, which plans to publish the first ANSI-approved GMP standard ...
(Date:3/29/2017)... ... March 29, 2017 , ... Curio Wellness , a ... the finalization of the company’s executive management team with prominent executives from both inside ... Curio Wellness’ Chief Operating Officer, Ted Dumbauld , who has more than twenty ...
(Date:3/29/2017)... ... March 29, 2017 , ... The assembly of synthetic DNA ... many repetitive steps and often scientists require many different versions of DNA. Therefore, ... results in a lower error rate and cost saving for reagents and consumables. ...
Breaking Medicine News(10 mins):